Categories Earnings, Health Care
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit.
- Third-quarter net sales increased 5% year-over-year to $1.75 billion; on a constant currency basis, the growth was 4.7%
- Revenues increased 6% annually in the United States, while international revenues moved up 3.6%
- Net income came in at $162.7 million or $0.77 per share in the September quarter, compared to $194 million or $0.92 per share a year earlier
- On an adjusted basis, Q3 profit increased to $1.65 per share from $1.58 per share in the prior-year period
- The company said it appointed Ivan Tornos as the president and chief executive officer
- The management expects reported revenue to grow in the range of 6.0% to 6.5% in fiscal 2023
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
